NDC Package 70710-1886-6 Lacosamide

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70710-1886-6
Package Description:
10 VIAL in 1 CARTON / 20 mL in 1 VIAL (70710-1886-1)
Product Code:
Proprietary Name:
Lacosamide
Non-Proprietary Name:
Lacosamide
Substance Name:
Lacosamide
Usage Information:
Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.
11-Digit NDC Billing Format:
70710188606
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 809974 - lacosamide 200 MG in 20 ML Injection
  • RxCUI: 809974 - 20 ML lacosamide 10 MG/ML Injection
  • RxCUI: 809974 - lacosamide 200 MG per 20 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Zydus Pharmaceuticals Usa Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    DEA Schedule:
    Schedule V (CV) Substances
    Sample Package:
    No
    FDA Application Number:
    ANDA209465
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-10-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70710-1886-6?

    The NDC Packaged Code 70710-1886-6 is assigned to a package of 10 vial in 1 carton / 20 ml in 1 vial (70710-1886-1) of Lacosamide, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 70710-1886 included in the NDC Directory?

    Yes, Lacosamide with product code 70710-1886 is active and included in the NDC Directory. The product was first marketed by Zydus Pharmaceuticals Usa Inc. on November 10, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 70710-1886-6?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 70710-1886-6?

    The 11-digit format is 70710188606. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-170710-1886-65-4-270710-1886-06